BD Accuri
BD Accuri
Accuri Cytometers was a very successful co-investment made by the Amherst Fund with Arboretum Ventures. Accuri successfully built its business making a low-cost, easy-to-use bench-top flow cytometer used in immunology and cell research. Accuri was acquired in 2011 by BD (Becton Dickinson), a worldwide medical technology company.
